0001450708
2015-11-01
2016-01-31
0001450708
2016-01-31
0001450708
us-gaap:CorporateJointVentureMember
aurm:CenturyConcessionMember
2015-11-01
2016-01-31
0001450708
us-gaap:PrincipalOwnerMember
2016-01-31
0001450708
us-gaap:CorporateJointVentureMember
aurm:CenturyConcessionMember
2010-12-31
0001450708
us-gaap:PrincipalOwnerMember
2009-07-31
0001450708
aurm:AxisConsultantsPtyLtdMember
2015-11-01
2016-01-31
0001450708
aurm:AxisConsultantsPtyLtdMember
2016-01-31
0001450708
aurm:ManagerOfLaosOperationsMember
2016-01-31
0001450708
country:US
2016-01-31
0001450708
us-gaap:CommonStockMember
aurm:FounderMember
us-gaap:PrivatePlacementMember
2008-09-01
2008-09-30
0001450708
us-gaap:CommonStockMember
aurm:PublicOfferingMember
2009-03-01
2009-03-31
0001450708
us-gaap:CommonStockMember
2015-11-01
2016-01-31
0001450708
us-gaap:CommonStockMember
2016-01-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2015-11-01
2016-01-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2016-01-31
0001450708
us-gaap:RetainedEarningsMember
2015-11-01
2016-01-31
0001450708
us-gaap:RetainedEarningsMember
2016-01-31
0001450708
us-gaap:MinimumMember
2015-11-01
2016-01-31
0001450708
us-gaap:MaximumMember
2015-11-01
2016-01-31
0001450708
us-gaap:SubsequentEventMember
aurm:MedicalTechnologyBusinessMember
us-gaap:ScenarioForecastMember
us-gaap:MaximumMember
2017-07-18
2017-07-19
0001450708
us-gaap:SubsequentEventMember
aurm:MedicalTechnologyBusinessMember
us-gaap:ScenarioForecastMember
2017-07-18
2017-07-19
0001450708
us-gaap:SubsequentEventMember
aurm:PayItSimpleMember
2016-04-01
0001450708
us-gaap:SubsequentEventMember
aurm:PayItSimpleMember
aurm:AdditionalEquityMethodInvestmentMember
2016-04-01
0001450708
us-gaap:SubsequentEventMember
aurm:PayItSimpleMember
aurm:InterestHoldingPercentageMember
2016-04-01
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
2016-06-27
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
aurm:WarrantsAndOptionsMember
2016-06-27
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
2016-06-01
2016-06-27
0001450708
us-gaap:SubsequentEventMember
us-gaap:CommonStockMember
2016-04-02
2016-04-30
0001450708
us-gaap:SubsequentEventMember
aurm:MedicalTechnologyBusinessMember
us-gaap:ScenarioForecastMember
2017-07-19
0001450708
us-gaap:SubsequentEventMember
us-gaap:CommonStockMember
2017-07-01
2017-07-31
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
aurm:FirstInstallmentAmountMember
2016-06-01
2016-06-27
0001450708
us-gaap:SubsequentEventMember
aurm:PayItSimpleMember
2016-04-02
2016-04-30
0001450708
us-gaap:SubsequentEventMember
aurm:HumavoxMember
2016-07-01
2016-07-31
0001450708
2015-10-31
0001450708
us-gaap:CommonStockMember
2015-10-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2015-10-31
0001450708
us-gaap:RetainedEarningsMember
2015-10-31
0001450708
aurm:ManagerOfLaosOperationsMember
2015-10-31
0001450708
aurm:AxisConsultantsPtyLtdMember
2015-10-31
0001450708
us-gaap:CommonStockMember
aurm:AxisConsultantsPtyLtdMember
2015-07-01
2015-07-31
0001450708
2014-11-01
2015-01-31
0001450708
2017-09-28
0001450708
2014-10-31
0001450708
2015-01-31
0001450708
us-gaap:CommonStockMember
2014-11-01
2015-10-31
0001450708
us-gaap:CommonStockMember
2014-10-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2014-11-01
2015-10-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2014-10-31
0001450708
us-gaap:RetainedEarningsMember
2014-11-01
2015-10-31
0001450708
us-gaap:RetainedEarningsMember
2014-10-31
0001450708
2014-11-01
2015-10-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
10-Q
false
2016-01-31
2016
Q1
AURM
AURUM, INC.
0001450708
--10-31
Smaller Reporting Company
54
197
54
197
216313
205355
216313
205355
1061723
829223
232500
1066827
232500
834327
13560
13560
7794983
7794983
-1277982
13560
7794983
-9086525
-1271985
13560
7794983
-9080528
-7502731
10560
2740207
-10253498
54
197
0.0001
0.0001
500000000
500000000
135600000
135600000
135600000
135600000
9600
9997
248
5
12570
26467
-12570
-26467
6573
818937
-5997
792470
-5997
-5997
792470
1172970
1172970
0.00
0.01
135600000
105600000
9000
12000
0.96
1.00
1.00
0.70
0.7286
0.51
827643
827643
827643
827643
96000000
9600000
250000
250000
30000000
135600000
135600000
105600000
2722
16465
135850000
1278036
1272182
1061723
1066827
-9086525
-9080528
6386
2028-01-31
2034-01-31
15000000
7500000
0.30
0.10
0.40
38329
38329
5057776
30000000
7500000
100000
100000
2500000
2500000
2500000
0.22
2500000
P24M
2012
0.22
1282
16000000
5500000
2016-04-06
2016-07-29
3000
5054776
5057776
0.7493
0.50
2285000
-963
1282
14894
1282
14894
187
-127
-143
-209
54
197
3073
2864
10958
10528
-1612
-14976
<div><div><table id="z0b9d322736d944ef9a0253bef602cb05" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">(1)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">ORGANIZATION AND BUSINESS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">Aurum, Inc. ("Aurum" or the "Company") is a Delaware corporation originally incorporated in Florida as Liquid Financial Engines, Inc. The principal stockholder of Aurum is Golden Target Pty Ltd., an Australian corporation ("Golden"), which owned 74.93% of Aurum as of January 31, 2016.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On January 20, 2010, the Company re-incorporated in the state of Delaware (the "Reincorporation") through a merger involving Liquid Financial Engines Inc. ("Liquid") and Aurum, Inc., a Delaware Corporation that was a wholly owned subsidiary of Liquid. The Reincorporation was effected by merging Liquid with Aurum, with Aurum being the surviving entity. For financial reporting purposes Aurum is deemed a successor to Liquid.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">In July 2009, Golden acquired a 96% interest in Aurum from certain stockholders. In connection therewith, the Company appointed a new President/Chief Executive Officer and Chief Financial Officer/Secretary and a new sole Director. The sole director and stockholder of Golden is also the President of the Company.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">Commencing August 2009, the Company decided to focus on mineral exploration for gold and copper in the Lao Peoples Democratic Republic (Lao P.D.R or Laos).</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">In December 2010, the Company executed a Management and Shareholders Agreement with Argonaut Overseas Investments Ltd ("AOI"), an indirectly wholly owned Subsidiary of Argonaut Resources N.L., in respect to Argonaut's 70% held Century Concession in Laos. The agreement appointed Aurum as the manager of the Century Thrust Joint Venture Agreement ("Joint Venture") and the Company had the right to earn 72.86% of AOI's interest in the Joint Venture which is equivalent to a 51% beneficial interest in the Century Concession.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Century Concession expired in fiscal 2014 and was not renewed. As a result, the Company no longer has any exploration interests in Laos.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On April 1, 2016 the Company announced that it had entered into an agreement with an Israeli company, PayItSimple Ltd and its subsidiaries (PayItSimple) whereby the Company would invest $15 million directly into PayItSimple by September 5, 2016 to acquire a 30% interest in PayItSimple, and a further $7.5 million into PayItSimple over 18 months to acquire a further 10% interest in PayItSimple, taking its holding to 40% of interest in PayItSimple.  PayItSimple owns a business known as Splitit. On April 6, 2016 the Company terminated the proposed acquisition of PayItSimple.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On June 27, 2016 the Company announced that it had entered into a binding term sheet with the shareholders of Israeli company, Humavox Ltd (Humavox), a company that creates wireless charging solutions. In accordance with the proposed acquisition of Humavox, Aurum would acquire 100% of the shares of Humavox and 100% of the warrants and options to acquire shares of Humavox in exchange for the issue of shares of common stock of Aurum representing 50% of the shares of common stock of Aurum post issue on a fully-diluted basis, including the investment of an amount of US$16 million in Humavox.  The investment would take place in unconditional instalments over a period of 24 months following the closing. The closing of the merger was subject to certain closing conditions, including the investment in Humavox of the first instalment of the investment in the amount of $5.5 million. On July 29, 2016 the Company terminated the proposed acquisition of Humavox.</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On July 19, 2017, the Company entered into a Term Sheet with Lior Wayn, Erez Glazer and Dr Guy Shalom, (collectively, the ''Sellers")  for the acquisition of all of the issued shares of a medical technology business. The Company has a 120 day period to conduct due diligence and negotiate a formal share sale agreement.</div>
<div style="text-align: justify; text-indent: 72pt; font: 10pt Times New Roman, Times, serif">The purchase price is up to USD$7,500,000 which is to be satisfied as follows:</div>
<div><br />
</div>
<div>
<table id="z4bb2fc4de8a2482e91d87faa6b6aae49" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">a)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The sum of USD$100,000 payable to the Sellers for due diligence expenses, 30 business days from the execution of the Term Sheet;</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div>
<table id="z88e87d50d1d64a7089be746b3511437b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">b)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif"> A further USD$100,000 each month after the date in a) above for due diligence expenses, for 3 months,  payable to the Sellers for working capital purposes;</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div>
<table id="zd71d533679694498b96b3470c7eb576e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">c)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">An issue of fully paid ordinary shares of common stock of the Company to the value of USD$2,500,000 (less any payments made to the Sellers under (a) and (b) above) to the Sellers at an issue price of USD$0.22 per share of common stock (Consideration Shares);</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div>
<table id="z1819bbc299944d5483721e8d80f4721d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">d)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion; and</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div>
<table id="z593bf676f4c847848da500be2dbdf483" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">e)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion.</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif">If the Transaction is terminated or is in the reasonable opinion of the Company unable to proceed at any point, the Vendors and the Sellers have agreed to convert any monies paid to the Sellers under (a) and (b) above into convertible securities in the Sellers.</div>
<div><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif">As part of the agreement and as a condition to completion, the Company will raise USD$2,500,000.</div>
<div><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif">Pending completion, the Sellers are required to carry on business in the ordinary course.</div>
<div><br />
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company's ability to continue operations for the foreseeable future is dependent upon future funding from affiliated entities, capital raisings, or its ability to commence revenue producing operations and positive cash flows.</div></div>
<div><div><table id="za3c39718007949b89dfe3f212e3fafed" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt"><tr><td style="width: 49px; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">(3)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">GOING CONCERN</div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has not yet commenced revenue producing operations and had a retained (deficit) of $9,086,525 as of January 31, 2016. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The Company will require additional funding for operations and this additional funding may be raised through debt or equity offerings. The Company has a debt due to AXIS Consultants Pty Ltd (AXIS). AXIS provides management services to the Company and the cost of these services increases the amount of the debt. Ina addition, the Company has historically relied on loans and advances from corporations affiliated with the President of Aurum, Inc. Based on discussions with these affiliate companies, the Company believes this source of funding will continue to be available. Other than the arrangements noted above, the Company has not confirmed any other arrangement for ongoing funding. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div></div>
<div><div><table id="z174302ab18ee4cdda1330e2d7a3e5250" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">(2)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">RECENT ACCOUNTING PRONOUNCEMENTS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif">The Company has implemented all new accounting pronouncements that are in effect and applicable to the Company. These pronouncements did not have any material impact on the consolidated financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</div></div>
<div><div><table id="zf9f083b9ee9649d1ae98bc41f0d2c0c0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">(4)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">AFFILIATE TRANSACTIONS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company entered into an agreement with AXIS to provide management and administration services to the Company. AXIS is affiliated through common management. The Company is one of nine affiliated companies to which AXIS provides services. Each of the companies has some common Directors, officers and shareholders. Currently, there are no material arrangements or planned transactions between the Company and any of the affiliated companies other than AXIS.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">During the three months ended January 31, 2016, AXIS provided services in accordance with the services agreement, incurred direct costs on behalf of the Company and provided funding of $1,282. During the three months ended January 31, 2016, the foreign exchange effect on the amounts owed to affiliates was a gain of $6,386. The amounts owed to AXIS as of January 31, 2016 and October 31, 2015 is $829,223 and $834,327, respectively. At January 31, 2016, the Company owed the former Managing Director of its Laos operation $232,500 (2015: $232,500). Both amounts are reflected in non-current liabilities - advance from affiliates. During the three months ended January 31, 2016 and 2015, the affiliates have agreed not to charge interest.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company intends to repay these amounts with funds raised either via additional debt or equity offerings. Both affiliates have agreed not to call the advance within the next twelve months and accordingly the Company has classified the amounts payable as non-current in the accompanying balance sheet.</div></div>
<div><div><table id="z8935b5e27b57466194ebcc662d7f2b3d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">(5)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">INCOME TAXES</div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company recognises deferred tax assets or liabilities for the expected future consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using the enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company is subject to taxation in the United States.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company's net deferred taxes at January 31, 2016 is summarized as follows:</div>
<table id="z6a6e0d4c16f943738286d796fc0b3cc3" border="0" cellspacing="0" cellpadding="0" align="left" style="width: 80%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="vertical-align: bottom; vertical-align: top"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top">
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">USA</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">2015</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">$</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top">
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">Total</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">2015</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">$</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Deferred tax assets</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; vertical-align: top"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; width: 76%; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Net operating loss carry-forward</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Less valuation allowance</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">(827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">(827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">)</div>
</td>
</tr>
<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Net deferred taxes</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td>
</tr>
</table>
<div style="margin-bottom: 10pt; clear: both"><br />
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company has available net operating loss carry forwards as of January 31, 2016, which are subject to limitations, aggregating approximately $2,285,000 which would expire in years 2028 through 2034.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company's tax returns for all years since fiscal 2012 remain open to examination by the respective tax authorities.  There are currently no tax examinations in progress.</div></div>
<div><div><table id="z74eed3da23fe4f1a8471a49c692eb1ec" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">(6)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">STOCKHOLDERS' EQUITY</div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">In September 2008, 96,000,000 shares of common stock were issued to the Company's founder raising $9,000.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">In March 2009, the Company raised $12,000 in a registered public offering of 9,600,000 shares of common stock share pursuant to a prospectus dated January 30, 2009.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On July 31, 2015, the Company issued 30,000,000 shares of common stock as repayment of a debt of $5,057,776.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On April 7, 2016, the Company raised $38,329 in a private placement through the offer of 250,000 shares of common stock.</div></div>
<div><div><table id="z72983184ab3746519ed9db748389d876" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">(7)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">FAIR VALUE OF FINANCIAL INSTRUMENTS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company's financial instruments consist of cash, receivables, accounts payable, accrued expenses and advances from affiliates. The carrying amounts of cash, receivables, accounts payables and accrued expenses approximates their fair values because of the short term maturities of those instruments. The fair value of advances from affiliates is not readily determinable as it is due to an affiliate entity, no similar market exists for these instruments and settlement date is uncertain.</div></div>
<div><div><table id="z79ddbd52aa0948b5ab110c9760ee484d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">(8)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">INCOME/(LOSS) PER SHARE</div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company calculates income/(loss) per share in accordance with ASC Topic 260, "Earnings per Share". Basic income/(loss) per share is computed based on the weighted average number of common shaes outstanding during the period.</div></div>
<div><div><table id="z19724918d7ff45c49a20de177f245b50" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">(9)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif; margin-bottom: 10pt">SUBSEQUENT EVENTS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company has evaluated significant events and transactions subsequent to the balance sheet date through the date the consolidated financial statements were issued, and believes that all relevant disclosures have been included herein and there are no other events or transactions which would require recognition or disclosure in the accompanying consolidated financial statements.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On April 1, 2016 the Company announced that it had entered into an agreement with an Israeli company, PayItSimple Ltd and its subsidiaries (PayItSimple) whereby the Company would invest $15 million directly into PayItSimple by September 5, 2016 to acquire a 30% interest in PayItSimple, and a further $7.5 million into PayItSimple over 18 months to acquire a further 10% interest in PayItSimple, taking its holding to 40% of interest in PayItSimple.  PayItSimple owns a business known as Splitit. On April 6, 2016 the Company terminated the proposed acquisition of PayItSimple.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On June 27, 2016 the Company announced that it had entered into a binding term sheet with the shareholders of an Israeli company, Humavox Ltd (Humavox), a company that creates wireless charging solutions. In accordance with the proposed acquisition of Humavox, Aurum would acquire 100% of the shares of Humavox and 100% of the warrants and options to acquire shares of Humavox in exchange for the issue of shares of common stock of Aurum representing 50% of the shares of common stock of Aurum post issue on a fully-diluted basis, including the investment of an amount of US$16 million in Humavox.  The investment would take place in unconditional instalments over a period of 24 months following the closing. The closing of the merger was subject to certain closing conditions, including the investment in Humavox of the first instalment of the investment in the amount of $5.5 million. On July 29, 2016 the Company terminated the proposed acquisition of Humavox.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">In April 2016, the Company raised $38,329 through the private placement of 250,000 shares of common stock.</div>
<div style="text-align: left; text-indent: 72pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On July 19, 2017, the Company entered into a Term Sheet with Lior Wayn, Erez Glazer and Dr Guy Shalom, (collectively, the ''Sellers")  for the acquisition of all of the issued shares of a medical technology business. The Company has a 120 day period to conduct due diligence and negotiate a formal share sale agreement.</div>
<div style="text-align: left; text-indent: 72pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The purchase price is up to USD$7,500,000 which is to be satisfied as follows:</div>
<div><br />
</div>
<div>
<table id="z1f17d040b3ff4e7b971caa2be8d87d91" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">f)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The sum of USD$100,000 payable to the Sellers for due diligence expenses, 30 business days from the execution of the Term Sheet;</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div>
<table id="z7b74a72c2bc248e8b09cf2230fcbd3a4" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">g)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif"> A further USD$100,000 each month after the date in a) above for due diligence expenses, for 3 months,  payable to the Sellers for working capital purposes;</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div>
<table id="zdb08919573bd42218ffaa741bcf31027" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">h)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">An issue of fully paid ordinary shares of common stock of the Company to the value of USD$2,500,000 (less any payments made to the Sellers under (a) and (b) above) to the Sellers at an issue price of USD$0.22 per share of common stock (Consideration Shares);</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div>
<table id="zc186a0c4dff54907a1f575afe48ddd83" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">i)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion; and</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div>
<table id="z2d0573bf2626470d85af1fda41c8682c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">j)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion.</div>
</td>
</tr>
</table>
</div>
<div><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif">If the Transaction is terminated or is in the reasonable opinion of the Company unable to proceed at any point, the Vendors and the Sellers have agreed to convert any monies paid to the Sellers under (a) and (b) above into convertible securities in the Sellers.</div>
<div><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif">As part of the agreement and as a condition to completion, the Company will raise USD$2,500,000.</div>
<div><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif">Pending completion, the Sellers are required to carry on business in the ordinary course.</div>
<div><br />
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">In July 2017, the Company raised $38,329 through the private placement of 250,000 shares of common stock.</div></div>
<div><div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The Company's net deferred taxes at January 31, 2016 is summarized as follows:</div>
<table id="z6a6e0d4c16f943738286d796fc0b3cc3" border="0" cellspacing="0" cellpadding="0" align="left" style="width: 80%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="vertical-align: bottom; vertical-align: top"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top">
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">USA</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">2015</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">$</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top">
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">Total</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">2015</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">$</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Deferred tax assets</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; vertical-align: top"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; width: 76%; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Net operating loss carry-forward</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 76%; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Less valuation allowance</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">(827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">(827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">)</div>
</td>
</tr>
<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 76%; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Net deferred taxes</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; vertical-align: bottom"> </td>
</tr>
</table></div>